Cancer Institute of New Jersey (CINJ), Melanoma & Soft Tissue Oncology

Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Melanoma & Soft Tissue Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Safety Medicine & Life Sciences
Autophagy Medicine & Life Sciences
Riluzole Medicine & Life Sciences
Oncolytic Viruses Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Janice Mehnert

Janice Mehnert

Person

20022020
No photo of Ann Silk

Ann Silk

Person

20032019

Projects 2014 2020

Wisconsin And New Jersey Alliance In Precision Experimental Therapeutics

Mehnert, J.

National Institutes of Health (NIH)

3/19/14 → 2/28/20

Project: Research project

Neoplasms
Clinical Trials
Therapeutics
Systems Biology
Pharmacogenetics

Research Output 2003 2019

A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors

Stein, M., Goodin, S., Gounder, M., Gibbon, D., Moss, R., Portal, D., Lindquist, D., Zhao, Y., Takebe, N., Tan, A., Aisner, J., Lin, H., Ready, N. & Mehnert, J., Jan 1 2019, (Accepted/In press) In : Investigational New Drugs.

Research output: Contribution to journal › Article

Carboplatin
Paclitaxel
Neoplasms
Area Under Curve
Prostate

A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors

Mehnert, J., Kaveney, A. D., Malhotra, J., Spencer, K., Portal, D., Goodin, S., Tan, A. R., Aisner, J., Moss, R. A., Lin, H., Bertino, J., Gibbon, D., Doyle, L. A., White, E. & Stein, M., Jan 1 2019, (Accepted/In press) In : Cancer chemotherapy and pharmacology.

Research output: Contribution to journal › Article

Hydroxychloroquine
Tumors
Neoplasms
Exanthema
Fatigue
3 Citations (Scopus)

Avelumab in patients with previously treated metastatic melanoma: Phase 1b results from the JAVELIN Solid Tumor trial

Keilholz, U., Mehnert, J., Bauer, S., Bourgeois, H., Patel, M. R., Gravenor, D., Nemunaitis, J. J., Taylor, M. H., Wyrwicz, L., Lee, K. W., Kasturi, V., Chin, K., Von Heydebreck, A. & Gulley, J. L., Jan 16 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 12.

Research output: Contribution to journal › Article

Melanoma
Neoplasms
Therapeutics
Disease-Free Survival
Survival